GSHWORLD has a total investment of 580 million yuan and an annual production of 1000 tons of NMN industrialization project has been approved! Competition is about to enter a white heat?
Approval of Jilin Provincial Department of Ecology and Environment on the Environmental Impact Report of Jilin GSH Bio-Technology Co.,LTD Enzymatic Production of B-Nicotinamide Mononucleic Acid (NMN) and Its Industrialization Project
This project is a new construction project located in the Fine Chemical Industry Zone of the North District of the Chemical Industry Park in Dunhua City. The main construction content includes the construction of new fermentation, purification, crystallization production workshops and production lines, supporting the construction of auxiliary, storage, transportation, public and environmental protection projects such as power recovery workshops, power stations, comprehensive buildings, tank farms, warehouses, sewage treatment stations, hazardous waste temporary storage rooms, accident emergency pools, etc. Design annual production after project completion β- Nicotinamide mononucleotide (NMN) 1000 tons.
The project complies with national industrial policies and the requirements of the “Overall Plan of Dunhua Chemical Industry Park” and the environmental impact assessment and ecological environment access list.
After fully implementing the pollution prevention and environmental risk prevention measures proposed in the environmental impact report,
the adverse effects of the project construction on the environment can alleviated and controlled.
Therefore, from the perspective of environmental protection, our department agrees in principle with the nature, scale, process, location,
and proposed environmental protection measures of the construction projects listed in the environmental impact report.
The total investment of this project is 580 million yuan, covering a total area of 61950.15 square meters and a total construction area of 32154.2 square meters. It mainly includes the construction of a fermentation workshop, purification workshop,
crystallization workshop, power recovery workshop, comprehensive office building, control room, power station, warehouse,
gate guard and Class A tank farm, as well as the installation of 8 production lines and corresponding public works.
Jilin GSH Bio-Technology Co.,LTD. Design annual production after project completion β- Nicotinamide Mononucleotide (NMN) 1000 tons
NMN Construction project introduction
Jilin GSH Bio-Technology Co., Ltd. a subsidiary wholly owned by Jilin GSH Bio-Technology Co., Ltd. Jilin GSH Bio-Technology Co., Ltd. a company engaged in bioengineering technology research,
as well as the development of new special drugs, health products, and cosmetics. It also cultivates, extracts, produces, processes, and sells precious Chinese medicinal materials. It integrates science, industry, trade, production, academia, and A private joint-stock enterprise integrating research and development.
The company wrote in the project introduction:
With the development of domestic and international β- The development of nicotinamide mononucleotide (NMN),
judged by the company β- The raw material of nicotinamide mononucleotide (NMN) will soon become insufficient to meet market demand.
One thought on “The total investment is 580 million and the NMN project has been approved”
Comments are closed.